BSE Live
Jan 23, 16:01Prev. Close
4055.60
Open Price
4055.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:55Prev. Close
4055.30
Open Price
4055.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Sanofi India (in Rs. Cr.) | Dec 14 | Dec 13 | Dec 12 | Dec 11 | Dec 10 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 | |
| Total Share Capital | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 | |
| Reserves and Surplus | 1,459.35 | 1,313.40 | 1,169.98 | 1,081.64 | 978.33 | |
| Total Reserves and Surplus | 1,462.81 | 1,323.67 | 1,181.09 | 1,093.59 | 991.12 | |
| Total Shareholders Funds | 1,485.84 | 1,346.70 | 1,204.12 | 1,116.62 | 1,014.15 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 53.88 | 36.69 | 21.28 | 8.46 | 15.47 | |
| Other Long Term Liabilities | 0.00 | 0.74 | 0.00 | 1.00 | 0.00 | |
| Long Term Provisions | 32.07 | 25.28 | 19.28 | 19.56 | 0.00 | |
| Total Non-Current Liabilities | 85.95 | 62.71 | 40.56 | 29.02 | 15.47 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 326.86 | 187.10 | 154.17 | 147.64 | 124.12 | |
| Other Current Liabilities | 110.04 | 89.93 | 84.99 | 70.90 | 49.58 | |
| Short Term Provisions | 218.92 | 158.35 | 147.47 | 138.36 | 220.56 | |
| Total Current Liabilities | 655.82 | 435.38 | 386.63 | 356.90 | 394.26 | |
| Total Capital And Liabilities | 2,227.61 | 1,844.79 | 1,631.31 | 1,502.54 | 1,423.88 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 266.21 | 254.00 | 194.25 | 167.36 | 144.44 | |
| Intangible Assets | 382.15 | 444.55 | 505.11 | 569.61 | 26.61 | |
| Capital Work-In-Progress | 207.81 | 136.20 | 40.63 | 20.51 | 13.30 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 858.24 | 834.75 | 742.83 | 759.83 | 184.35 | |
| Non-Current Investments | 0.24 | 0.24 | 0.36 | 0.36 | 0.36 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 25.32 | |
| Long Term Loans And Advances | 104.81 | 61.59 | 58.18 | 74.98 | 0.00 | |
| Other Non-Current Assets | 1.50 | 1.07 | 2.64 | 0.63 | 0.00 | |
| Total Non-Current Assets | 964.79 | 897.65 | 804.01 | 835.80 | 210.03 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 478.09 | 340.00 | 272.45 | 254.27 | 241.32 | |
| Trade Receivables | 115.22 | 118.31 | 98.60 | 104.09 | 60.44 | |
| Cash And Cash Equivalents | 468.84 | 264.40 | 428.85 | 234.23 | 655.35 | |
| Short Term Loans And Advances | 196.14 | 219.12 | 23.30 | 67.73 | 256.74 | |
| OtherCurrentAssets | 4.53 | 5.31 | 4.10 | 6.42 | 0.00 | |
| Total Current Assets | 1,262.82 | 947.14 | 827.30 | 666.74 | 1,213.85 | |
| Total Assets | 2,227.61 | 1,844.79 | 1,631.31 | 1,502.54 | 1,423.88 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 249.66 | 296.19 | 143.32 | 169.27 | 135.38 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 285.14 | 215.59 | 192.45 | 187.19 | 330.05 | |
| Stores, Spares And Loose Tools | 435.69 | 312.60 | 231.13 | 190.28 | 0.00 | |
| Trade/Other Goods | 435.69 | 312.60 | 231.13 | 190.28 | 0.00 | |
| Capital Goods | 8.49 | 13.14 | 8.77 | 5.41 | 0.96 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 12.08 | 8.34 | 8.07 | 8.85 | 4.08 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 13.91 | 54.25 | 45.90 | 76.50 | 28.51 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 478.79 | 415.17 | 244.67 | 219.53 | 206.69 | |
| Other Earnings | 70.73 | 71.31 | 75.66 | 85.45 | 175.31 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 18.38 | 18.38 | 18.38 | 18.38 | 18.38 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | 32.08 | 13.36 | 19.84 | |
| Non-Current Investments Unquoted Book Value | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y